REFERENCES
- ACGIH: Threshold Limit Values for Chemical Substances and Physical Agents, and Biological Exposure Indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 2007;35.
- Kabe I, : In vitro solubility and in vivo toxicity of indium phosphide. J Occup Health. 1996;38:6–12.
- Oda K: Toxicity of a low level of indium phosphide (InP) in rats after intratracheal instillation. Ind Health. 1997;35(1):61–68.
- Uemura T, : Effects of intratracheally administered indium phosphide on male Fischer 344 rats. J Occup Health. 1997;39:205–210.
- Omura M, : Testicular toxicity of gallium arsenide, indium arsenide, and arsenic oxide in rats by repetitive intratracheal instillation. Fundam Appl Toxicol. 1996;32:72–78.
- Tanaka A, : Chronic toxicity of indium arsenide and indium phosphide to the lungs of hamsters. Fukuoka Igaku Zasshi. 1996;87:108–115.
- Tanaka A, : Comparative study of the toxic effects of gallium arsenide, indium arsenide and arsenic trioxide following intratracheal instillations to the lung of Syrian golden hamsters. Fukuoka Igaku Zasshi. 2000;91:21–33.
- Morgan DL, : Acute pulmonary toxicity of copper gallium diselenide, copper indium diselenide, and cadmium telluride intratracheally instilled into rats. Environ Res. 1995;71:16–24.
- Tanaka A, : Pulmonary toxicity of indium-tin oxide and indium phosphide after intratracheal instillations into the lung of hamsters. J Occup Health. 2002;44:99–102.
- Chonan T, Taguchi O, Omae K: Interstitial pulmonary disorders in indium-processing workers. Eur Respir J. 2007;29:317–324.
- Homma T, : Interstitial pneumonia developed in a worker dealing with particles containing indium-tin oxide. J Occup Health. 2003;45:137–139.
- Homma S, : Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide. Eur Respir J. 2005;25:200–204.
- Hamaguchi T, : Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage. Occup Environ Med. 2008;65:51–55.
- Taguchi O, Chonan T: Three cases of indium lung. Nihon Kokyuki Gakkai Zasshi. 2006;44:532–536.
- NTP, Toxicology and carcinogenesis studies of indium phosphide (CAS no. 22398–90-7) in F344/N rats and B6C3F1 mice (inhalation studies). National Toxicology Program Techical Report Series; 2001;7–340.
- McNulty JC: Malignant pleural mesothelioma in an asbestos worker. Med J Aust. 1962;49:953–954.
- Wagner JC, Sleggs CA, Marchand P: Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260–271.
- Hesterberg TW, : Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the syrian golden hamster. Part I. Results of a subchronic study and dose selection for a chronic study. Inhal Toxicol. 1999;11:747–784.
- Foster WM, : Methodology for the measurement of mucociliary function in the mouse by scintigraphy. J Appl Physiol. 2001;90:1111–1117.
- Card JW, : Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation. J Immunol. 2006;177:621–630.
- Card JW, : Cyclooxygenase-2 deficiency exacerbates bleomycin-induced lung dysfunction but not fibrosis. Am J Respir Cell Mol Biol. 2007;37:300–308.
- Kirby PK, : Pleural effects of indium phosphide in B6C3F1 mice: nonfibrous particulate induced pleural fibrosis. Exp. Lung Res. 2009, in press.
- Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
- Noppen M: Normal volume and cellular contents of pleural fluid. Curr Opin Pulm Med. 2001;7:180–182.
- Noppen M: Normal volume and cellular contents of pleural fluid. Paediatr Respir Rev. 2004;5(Suppl A):S201–S203.
- Henderson RF: Bronchoalveolar lavage: a tool for assessing the health status of the lung. In: McClellam RO, Henderson RF, eds. Concepts in Inhalation Toxicology. New York: Hemisphere; 1989;415–444.
- Stephens M, et al: Asbestos induced diffuse pleural fibrosis: pathology and mineralogy. Thorax. 1987;42:583–588.
- Huggins JT, Sahn SA: Causes and management of pleural fibrosis. Respirology. 2004;9:441–447.
- Jantz MA, Antony VB: Pleural fibrosis. Clin Chest Med. 2006;27:181–191.
- Mutsaers SE, : Growth factors in pleural fibrosis. Curr Opin Pulm Med. 2006;12:251–258.
- Mutsaers SE, : Pathogenesis of pleural fibrosis. Respirology. 2004;9:428–440.
- Jantz MA, Antony VB: Pathophysiology of the pleura. Respiration. 2008;75:121–133.
- Gomez DE, : Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74:111–122.
- Iglesias D, : Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Eur Respir J. 2005;25:104–109.
- Decologne N, : TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol. 2007;179:6043–6051.
- Davis JM, Jones AD: Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol. 1988;69:717–737.
- Dittmar TB, : Surface concentrations of indium, phosphorus, and oxygen in indium phosphide single crystals after exposure to Gamble solution. Anal Chem. 1992;64:2929–2933.
- Galle P, Berry JP, Galle C: Role of alveolar macrophages in precipitation of mineral elements inhaled as soluble aerosols. Environ Health Perspect. 1992;97:145–147.
- Gjomarkaj M, : Phenotypic and functional characterization of normal rat pleural macrophages in comparison with autologous peritoneal and alveolar macrophages. Am J Respir Cell Mol Biol. 1999;20:135–142.
- Antony VB: Immunological mechanisms in pleural disease. Eur Respir J. 2003;21:539–544.
- Quintana HK, : Identification with MRI of the pleura as a major site of the acute inflammatory effects induced by ovalbumin and endotoxin challenge in the airways of the rat. Am J Physiol Lung Cell Mol Physiol. 2006;291:L651–L657.